Clinical Trial Update: Study to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution Versus Vehicle in Patients With Glaucoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and efficacy of rhNGF eye drops vs vehicle in glaucoma completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• rhNGF eye drops solution (recombinant human nerve growth factor)

Snippet

Sponsor: Dompé Farmaceutici S.p.A | Conditions: Glaucoma | Phase 1 | Status: COMPLETED | Results posted: 2020-11-25